These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 367679)

  • 41. Alternating chemoradiotherapy versus partly accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck: results from a phase III randomized trial.
    Corvò R; Benasso M; Sanguineti G; Lionetto R; Bacigalupo A; Margarino G; Pallestrini E; Merlano M; Vitale V; Rosso R
    Cancer; 2001 Dec; 92(11):2856-67. PubMed ID: 11753959
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early results of the EORTC randomized clinical trial on multiple fractions per day (MFD) and misonidazole in advanced head and neck cancer.
    van den Bogaert W; van der Schueren E; Horiot JC; Chaplain G; Devilhena M; Raposo S; Leonor J; Schraub S; Chenal C; Barthelme E
    Int J Radiat Oncol Biol Phys; 1986 Apr; 12(4):587-91. PubMed ID: 3516953
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Postoperative radiotherapy for primary mucosal melanoma of the head and neck.
    Temam S; Mamelle G; Marandas P; Wibault P; Avril MF; Janot F; Julieron M; Schwaab G; Luboinski B
    Cancer; 2005 Jan; 103(2):313-9. PubMed ID: 15578718
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The CHART regimen and morbidity.
    Dische S; Saunders MI
    Acta Oncol; 1999; 38(2):147-52. PubMed ID: 10227434
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mucosal melanoma of the head and neck.
    Wagner M; Morris CG; Werning JW; Mendenhall WM
    Am J Clin Oncol; 2008 Feb; 31(1):43-8. PubMed ID: 18376227
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A controlled trial of hyperbaric oxygen in the radiotherapy of head and neck tumours.
    Kunkler PB; Boulis-Wassif S; Shah NK; Sutherland WH; Smith C
    Br J Radiol; 1968 Jul; 41(487):557. PubMed ID: 4872848
    [No Abstract]   [Full Text] [Related]  

  • 47. Evolution of the Radiation Therapy Oncology Group clinical trials for head and neck cancer.
    Fu KK; Cooper JS; Marcial VA; Laramore GE; Pajak TF; Jacobs J; Al-Sarraf M; Forastiere AA; Cox JD
    Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):425-38. PubMed ID: 8655364
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Concomitant boost radiotherapy compared with conventional radiotherapy in squamous cell carcinoma of the head and neck--a phase III trial from a single institution in India.
    Ghoshal S; Goda JS; Mallick I; Kehwar TS; Sharma SC
    Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):212-20. PubMed ID: 18343310
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hyperbaric oxygenation for tumour sensitisation to radiotherapy.
    Bennett M; Feldmeier J; Smee R; Milross C
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005007. PubMed ID: 16235387
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reduction of the dose of radiotherapy to the elective neck in head and neck squamous cell carcinoma; a randomized clinical trial. Effect on late toxicity and tumor control.
    Nevens D; Duprez F; Daisne JF; Dok R; Belmans A; Voordeckers M; Van den Weyngaert D; De Neve W; Nuyts S
    Radiother Oncol; 2017 Feb; 122(2):171-177. PubMed ID: 27528118
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Postoperative adjuvant radiation therapy in the treatment of primary head and neck mucosal melanomas.
    Nakashima JP; Viégas CM; Fassizoli AL; Rodrigues M; Chamon LA; Silva JH; Dias FL; Araújo CM
    ORL J Otorhinolaryngol Relat Spec; 2008; 70(6):344-51. PubMed ID: 18984969
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence and peak incidence of acute and late normal tissue morbidity in the DAHANCA 6&7 randomised trial with accelerated radiotherapy for head and neck cancer.
    Mortensen HR; Overgaard J; Specht L; Overgaard M; Johansen J; Evensen JF; Andersen LJ; Andersen E; Grau C
    Radiother Oncol; 2012 Apr; 103(1):69-75. PubMed ID: 22398313
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A preliminary clinical study in the use of misonidazole in cancer of the head and neck.
    Sealy R
    Br J Cancer Suppl; 1978 Jun; 3():314-7. PubMed ID: 277253
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Altered fractionation: limited by mucosal reactions?
    Kaanders JH; van der Kogel AJ; Ang KK
    Radiother Oncol; 1999 Mar; 50(3):247-60. PubMed ID: 10392810
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: long-term follow-up results of RTOG 83-13.
    Fu KK; Pajak TF; Marcial VA; Ortiz HG; Rotman M; Asbell SO; Coia LR; Vora NL; Byhardt R; Rubin P
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):577-88. PubMed ID: 7790242
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Institutional experience of interstitial brachytherapy for head and neck cancer with a comparison of high- and low dose rate practice.
    Mohanti BK; Sahai P; Thakar A; Sikka K; Bhasker S; Sharma A; Sharma S; Bahadur S
    Asian Pac J Cancer Prev; 2014; 15(2):813-8. PubMed ID: 24568501
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Treatment of head and neck cancer: radiation therapy].
    Chatani M; Yoshino K
    Gan To Kagaku Ryoho; 1996 Feb; 23(3):271-6. PubMed ID: 8712818
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neutron therapy for head and neck cancer: II. Further follow-up on the M. D. Anderson TAMVEC randomized clinical trial.
    Maor MH; Hussey DH; Barkley HT; Peters LJ
    Int J Radiat Oncol Biol Phys; 1983 Sep; 9(9):1261-5. PubMed ID: 6350242
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dose-response relationships for late effects on skin and mucosa.
    Turesson I
    Recent Results Cancer Res; 1993; 130():49-57. PubMed ID: 8362099
    [No Abstract]   [Full Text] [Related]  

  • 60. Radiation-free weekend rescued! Continuous accelerated irradiation of 7-days per week is equal to accelerated fractionation with concomitant boost of 7 fractions in 5-days per week: report on phase 3 clinical trial in head-and-neck cancer patients.
    Skladowski K; Hutnik M; Wygoda A; Golen M; Pilecki B; Przeorek W; Rutkowski T; Lukaszczyk-Widel B; Heyda A; Suwinski R; Tarnawski R; Maciejewski B
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):741-6. PubMed ID: 22836063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.